A pharmacological investigation of human isolated stomach.
D000109:Acetylcholine / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology*; D004877:Ergoloid Mesylates / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology*; D006145:Guanethidine / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D008012:Lidocaine / Q000494:pharmacology*; D008784:Methysergide / Q000494:pharmacology*; D009388:Neostigmine / Q000494:pharmacology*; D009538:Nicotine / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010425:Pentolinium Tartrate / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology*; D012601:Scopolamine / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology*
D004983:Ethanolamines; D006584:Hexamethonium Compounds; D006634:Histamine H1 Antagonists; D010879:Piperazines; D013566:Sympathomimetics; D012701:Serotonin; D009388:Neostigmine; D011189:Potassium Chloride; D009538:Nicotine; D004877:Ergoloid Mesylates; D006632:Histamine; D010425:Pentolinium Tartrate; D008012:Lidocaine; D010830:Physostigmine; D012601:Scopolamine; D003042:Cocaine; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D008784:Methysergide; D004837:Epinephrine; D006145:Guanethidine